Keppler D, Konig J
Division of Tumor Biochemistry, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
FASEB J. 1997 Jun;11(7):509-16. doi: 10.1096/fasebj.11.7.9212074.
The liver converts endogenous and xenobiotic lipophilic compounds into anionic conjugates with glutathione, glucuronate, or sulfate. These conjugates are transported across the canalicular (apical) membrane into bile by a 190 kDa membrane glycoprotein that has been cloned recently. This apical conjugate-transporting ATPase has been termed canalicular multidrug resistance protein (cMRP) because of the similarity in substrate specificity and sequence with the multidrug resistance protein (MRP1), canalicular multispecific organic anion transporter (cMOAT), or multidrug resistance protein 2 (MRP2). The amino acid sequence identity of human MRP2 and MRP1 is 49%. MRP2 is predominantly expressed in hepatocytes and localized to apical membrane domains. MRP2 is not expressed in the human Dubin-Johnson syndrome, which is therefore associated with an inherited deficiency in the secretion of amphiphilic anionic conjugates into the bile. The rat homolog Mrp2 is absent in two mutant strains of rats with different point mutations in the corresponding gene. These mutant rats are hyperbilirubinemic and deficient in the ATP-dependent transport of conjugates from hepatocytes into bile. Impairment of bile flow (cholestasis) can be associated with a down-regulation of the expression of the conjugate export pump, and MRP2 contributes to bile flow as an important driving force.
肝脏将内源性和外源性亲脂性化合物转化为与谷胱甘肽、葡萄糖醛酸或硫酸盐结合的阴离子共轭物。这些共轭物通过一种最近已被克隆的190 kDa膜糖蛋白转运穿过胆小管(顶端)膜进入胆汁。这种顶端共轭物转运ATP酶由于其底物特异性和序列与多药耐药蛋白(MRP1)、胆小管多特异性有机阴离子转运体(cMOAT)或多药耐药蛋白2(MRP2)相似,而被称为胆小管多药耐药蛋白(cMRP)。人类MRP2和MRP1的氨基酸序列同一性为49%。MRP2主要在肝细胞中表达,并定位于顶端膜结构域。人类杜宾-约翰逊综合征中不表达MRP2,因此该综合征与两亲性阴离子共轭物向胆汁中分泌的遗传性缺陷有关。大鼠同源物Mrp2在相应基因中有不同点突变的两种大鼠突变品系中不存在。这些突变大鼠患有高胆红素血症,且从肝细胞向胆汁中进行共轭物的ATP依赖性转运存在缺陷。胆汁流动受损(胆汁淤积)可能与共轭物输出泵表达的下调有关,而MRP2作为一种重要的驱动力对胆汁流动有贡献。